Want to see SE:LINC full AI Analyst Report?
LINC Stock Chart & Stats
kr69.40
-kr0.60(-0.89%)
At close: 4:00 PM EST
kr69.40
-kr0.60(-0.89%)
Day’s Range― - ―
52-Week Rangekr58.90 - kr83.60
Previous CloseN/A
Volume35.92K
Average Volume (3M)47.06K
Market Cap
kr4.33B
Enterprise Valuekr3.95K
Total Cash (Recent Filing)kr169.95M
Total Debt (Recent Filing)kr0.00
Price to Earnings (P/E)13.4
Beta0.79
Next Earnings
Oct 22, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)5.64
Shares Outstanding57,910,446
10 Day Avg. Volume58,577
30 Day Avg. Volume47,060
Financial Highlights & Ratios
PEG Ratio0.08
Price to Book (P/B)0.91
Price to Sales (P/S)415.95
P/FCF Ratio-15.19
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Strong Balance SheetZero reported debt and a substantial equity base materially reduce financial risk and give Linc flexibility to hold or support portfolio companies through long development cycles. This durable low-leverage position preserves optionality for exits, follow-on investments, and opportunistic capital deployment.
Life-science Focus & Active OwnershipA focused life-science investment model combined with active ownership supports durable value creation: sector expertise improves sourcing and oversight, and hands-on governance can accelerate portfolio operational improvements and exit readiness across multi-year biotech development cycles.
Monetization Via Capital Gains And Fair-value MovesLinc's core monetization—capital gains and fair-value revaluations—is a structural strength for an investment vehicle: realized exits and uplifts from listings or trade sales can deliver step-change NAV improvements that compound over multi-year horizons, enabling long-term shareholder value creation.
Bears Say
Volatile ProfitabilityEarnings have swung materially between strong gains and large losses, indicating returns are heavily driven by episodic valuation events rather than steady operating performance. This volatility reduces predictability of NAV progression and complicates planning for distributions or reinvestment over multi-quarter horizons.
Inconsistent Cash GenerationHistoric negative operating and free cash flows in multiple years show weak cash conversion of reported earnings. Reliance on non-cash fair-value gains increases liquidity uncertainty and can limit capacity for recurring distributions or funding portfolio companies without asset sales or external financing.
Very Small Operating TeamAn extremely lean headcount constrains internal capacity for sourcing, monitoring and hands-on development across multiple life-science investments. This increases reliance on external partners or managers and may limit the firm’s ability to scale active ownership and operational involvement as the portfolio grows.
LINC FAQ
What was Linc AB’s price range in the past 12 months?
Linc AB lowest stock price was kr58.90 and its highest was kr83.60 in the past 12 months.
What is Linc AB’s market cap?
Linc AB’s market cap is kr4.33B.
When is Linc AB’s upcoming earnings report date?
Linc AB’s upcoming earnings report date is Oct 22, 2026 which is in 91 days.
How were Linc AB’s earnings last quarter?
Linc AB released its earnings results on Jul 16, 2026. The company reported kr4.457 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Linc AB overvalued?
According to Wall Street analysts Linc AB’s price is currently Overvalued.
Does Linc AB pay dividends?
Linc AB does not currently pay dividends.
What is Linc AB’s EPS estimate?
Linc AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Linc AB have?
Linc AB has 57,910,446 shares outstanding.
What happened to Linc AB’s price movement after its last earnings report?
Linc AB reported an EPS of kr4.457 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 3.239%.
Which hedge fund is a major shareholder of Linc AB?
Currently, no hedge funds are holding shares in SE:LINC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Linc AB
Linc AB operates as a private equity and venture capital firm, dedicating its investments to the pharmaceutical, life sciences, and med-tech sectors across early, mid, and late venture stages. The firm prioritizes investment opportunities within Nordic companies. Its typical investment amounts range from SEK 25 million to SEK 250 million, frequently beginning with a relatively smaller initial capital injection, with subsequent follow-up investments constituting the majority of its financial commitment. Linc AB's headquarters are located in Stockholm, Sweden.
Technical Analysis
Creades AB
―
Idun Industrier AB Class B
―
Vo2 Cap Holding AB
―
Svolder AB Class B
―
MedCap AB
―